UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)
UnitedHealth Group Incorporated delivered a strong Q2, with improved medical care ratio and operating income up 50% YoY, signaling effective cost initiatives. UNH raised FY 2026 EPS guidance to $19.5–$20, reflecting operational recovery and solid cash flow prospects, especially from Optum's AI-driven growth. Despite operational improvements, UNH's valuation now trades above its 5-year average P/E, reducing risk-reward asymmetry and margin of safety.
UnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlook
Shares of UnitedHealth Group jumped to their highest level in more than a year Thursday after the health care and insurance giant announced results that handily topped Wall Street expectations.
UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.
UnitedHealth Group Incorporated (UNH) Q2 2026 Earnings Call Transcript
UnitedHealth Group Incorporated (UNH) Q2 2026 Earnings Call Transcript
UnitedHealth Group: A Return To Glory Days
UnitedHealth Group Incorporated has delivered a major earnings inflection, with Q2 results significantly exceeding expectations and a robust outlook upgrade. UNH's Q2 adjusted EPS of $6.38 crushed consensus by $1.46, driven by strict cost discipline, improved MCR, and operational efficiency across all segments. Management raised 2026 adjusted EPS guidance to $19.50–$20.00 and operating cash flow to $24 billion, reflecting strong execution and confidence.
UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported adjusted earnings of $6.38 per share, ahead of analysts' expectations of about $4.91 per share.
UnitedHealth: Huge Q2 Beat Proves Turnaround Is In Full Force
UnitedHealth Group Incorporated delivered a strong Q2, with EPS beating consensus by 30% and margins rebounding sharply. UNH's turnaround strategy prioritizes margin restoration over customer growth, evidenced by a deliberate reduction in insured patients and improved operating discipline. Management raised 2026 guidance, projecting $19.50–$20.00 EPS and $24B in operating cash flow, supporting increased buybacks and a 2%+ dividend yield.
UnitedHealth (UNH) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UnitedHealth Group Q2 Earnings Call Highlights
UnitedHealth Group NYSE: UNH reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that business.
UnitedHealth Stock Surges After Blowout Q2 Beat-and-Raise
Insurance leader UnitedHeath Group Inc (NYSE:UNH) is surging 7.6% to trade at $418.52 before the bell, after the company posted a blowout second-quarter earnings and revenue beat.
UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates
UnitedHealth Group (UNH) came out with quarterly earnings of $6.38 per share, beating the Zacks Consensus Estimate of $4.94 per share. This compares to earnings of $4.08 per share a year ago.
UnitedHealth stock jumps 6% after earnings beat, raised 2026 profit forecast
UnitedHealth Group raised its full-year profit outlook on Thursday after reporting second-quarter earnings that comfortably exceeded Wall Street expectations, signalling that the health insurer's turnaround efforts are beginning to gain traction even as elevated medical costs continue to weigh on the broader industry. Shares of the company rose more than 6% in premarket trading after the largest private health insurer in the United States posted stronger-than-expected earnings, improved profitability, and a lower medical cost ratio.
